Τρίτη 3 Μαρτίου 2020


Analysis of the Genetic Characteristics of a Chinese Family With Otosclerosis
Ear, Nose &Throat Journal, Ahead of Print. Background:Otosclerosis is a focal lesion of the inner ear. The role of genetic factors in the pathogenesis of otosclerosis has received increasing attention. We analyzed the clinical manifestations, inheritance pattern, and pathogenic genes in a family with otosclerosis.Methods:We collected clinical data and generated a family pedigree. High-throughput second-generation sequencing technology was used to identify candidate genes by performing whole-exome...
SAGE Publications: Ear, Nose & Throat Journal: Table of Contents
06:19
Airway Considerations in Transgender Patients: Complicated Intubation
Ear, Nose &Throat Journal, Ahead of Print.
SAGE Publications: Ear, Nose & Throat Journal: Table of Contents
06:19
The Elevation of Tympanomeatal Skin Flap Could Not be Necessary for Endoscopic Cartilage Myringoplasty
Ear, Nose &Throat Journal, Ahead of Print. Endoscope provide the excellent view and observe the entire perforation edges, endoscopic cartilage myringoplasty doesn’t require the lateral circumferential incision and the elevation of tympanomeatal skin flap in most cases. The cartilage graft may be pushed through the perforation and place medial to the remnant tympanic membrane and annulus.
SAGE Publications: Ear, Nose & Throat Journal: Table of Contents
06:19
Geniculate Ganglion Hemangioma Visualized Through Perforated Tympanic Membrane
Ear, Nose &Throat Journal, Ahead of Print.
SAGE Publications: Ear, Nose & Throat Journal: Table of Contents
06:19
Calcified Infratemporal Mass: Osteochondroma
Ear, Nose &Throat Journal, Ahead of Print.
SAGE Publications: Ear, Nose & Throat Journal: Table of Contents
06:19
Factbox: Airlines suspend flights due to coronavirus outbreak
Airlines have been suspending flights or modifying services in response to the coronavirus outbreak.
Reuters: Health News
08:28
Roche gets U.S. breakthrough tag for liver cancer diagnosis approach
Roche has won fast-track review status in the United States for a new diagnostic approach that the Swiss drugmaker hopes will support its push into treating liver cancer with drugs including its immunotherapy Tecentriq.
Reuters: Health News
08:27

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου